Pregabalin
Brand name: Pregabalin
Rank #131 of 500 drugs by total cost
$124.3M
Total Cost
2,696,923
Total Claims
$124.3M
Total Cost
61,412
Prescribers
$46
Cost per Claim
464,558
Beneficiaries
3,422,925
30-Day Fills
$2,024
Avg Cost/Provider
44
Avg Claims/Provider
About Pregabalin
Pregabalin (sold as Pregabalin) was prescribed 2,696,923 times by 61,412 Medicare Part D providers in 2023, costing the program $124.3M. At $46 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 128 | Umeclidinium Bromide (Incruse Ellipta) | $131.6M | 290,677 |
| 129 | Tiotropium Br/Olodaterol Hcl (Stiolto Respimat) | $130.3M | 201,233 |
| 130 | Immun Globg(Igg)/Malt/Iga Ov50 (Octagam) | $129.5M | 9,657 |
| 131 | Pregabalin (Pregabalin) | $124.3M | 2,696,923 |
| 132 | Dronedarone Hcl (Multaq) | $123.4M | 98,156 |
| 133 | Brimonidine Tartrate/Timolol (Brimonidine Tartrate-Timolol) | $122.0M | 361,001 |
| 134 | Olaparib (Lynparza) | $121.1M | 8,744 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology